Gavriatopoulou M, Kastritis E, Kyrtsonis M-C, Vassilakopoulos TP, Roussou M, Fotiou D, Migkou M, Mpakiri M, Tasidou A, Terpos E, et al. Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström’s macroglobulinemia. Leukemia and Lymphoma [Internet]. 2016:1 - 3.